Pyrimethamine Market 2027 By Type, Applications | The Insight Partners

Pyrimethamine Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Injectables, Capsules, Tablets); Applications (Hospital, Clinic, Laboratory, Others)

Report Code: TIPRE00011117 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Pyrimethamine is a medication used for protozoan infections. It is commonly used as an antimalarial drug (for both treatment and prevention of malaria), and to treat Toxoplasma gondii infections, particularly when combined with the sulfonamide antibiotic sulfadiazine when treating HIV-positive individuals. Pyrimethamine is typically given with a sulfonamide and folinic acid due to its resistance against many Plasmodium species. Pyrimethamine has also been found to limit the expression of the superoxide dismutase 1 gene, a protein involved in amyotrophic lateral sclerosis.

MARKET DYNAMICS

The pyrimethamine market is driving due to the rising number of HIV positive patients worldwide and immunosuppressed individual at a risk of infections. However, factors such as pricing issues in some countries and resistance developing against the drugs may hamper the growth of market during the forecast period. Moreover, mergers and acquisitions by the manufacturing companies would also the boost the demand and supply for the pyrimethamine medication in the pyrimethamine treatment market.

MARKET SCOPE

The "Pyrimethamine Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of pyrimethamine market with detailed market segmentation by of product, technology, application and end user. The pyrimethamine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pyrimethamine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The pyrimethamine market is segmented on the basis of type, and application. Based on type, the market is segmented as injectables, capsules and tablets. On the basis of application, the market is categorized as hospital, clinic, laboratory and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pyrimethamine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pyrimethamine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pyrimethamine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pyrimethamine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the pyrimethamine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pyrimethamine market are anticipated to have lucrative growth opportunities in the future with the rising demand for pyrimethamine in the global market. Below mentioned is the list of few companies engaged in the pyrimethamine market.

The report also includes the profiles of key players in pyrimethamine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Evaluate
  •   GlaxoSmithKline plc
  •   Impax Laboratories, Inc.
  •   NCBO BioPortal
  •   Pfizer, Inc.
  •   PRN Pharmacal
  •   SUDA Pharmaceuticals
  •   Taj Accura Pharmaceuticals
  •   TargetMol
  •   Turing Pharmaceuticals


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pyrimethamine Market - By Type
1.3.2 Pyrimethamine Market - By Applications
1.3.3 Pyrimethamine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PYRIMETHAMINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PYRIMETHAMINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PYRIMETHAMINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PYRIMETHAMINE - GLOBAL MARKET OVERVIEW
6.2. PYRIMETHAMINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PYRIMETHAMINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INJECTABLES
7.3.1. Overview
7.3.2. Injectables Market Forecast and Analysis
7.4. CAPSULES
7.4.1. Overview
7.4.2. Capsules Market Forecast and Analysis
7.5. TABLETS
7.5.1. Overview
7.5.2. Tablets Market Forecast and Analysis
8. PYRIMETHAMINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. LABORATORY
8.5.1. Overview
8.5.2. Laboratory Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PYRIMETHAMINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pyrimethamine Market Overview
9.1.2 North America Pyrimethamine Market Forecasts and Analysis
9.1.3 North America Pyrimethamine Market Forecasts and Analysis - By Type
9.1.4 North America Pyrimethamine Market Forecasts and Analysis - By Applications
9.1.5 North America Pyrimethamine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pyrimethamine Market
9.1.5.1.1 United States Pyrimethamine Market by Type
9.1.5.1.2 United States Pyrimethamine Market by Applications
9.1.5.2 Canada Pyrimethamine Market
9.1.5.2.1 Canada Pyrimethamine Market by Type
9.1.5.2.2 Canada Pyrimethamine Market by Applications
9.1.5.3 Mexico Pyrimethamine Market
9.1.5.3.1 Mexico Pyrimethamine Market by Type
9.1.5.3.2 Mexico Pyrimethamine Market by Applications
9.2. EUROPE
9.2.1 Europe Pyrimethamine Market Overview
9.2.2 Europe Pyrimethamine Market Forecasts and Analysis
9.2.3 Europe Pyrimethamine Market Forecasts and Analysis - By Type
9.2.4 Europe Pyrimethamine Market Forecasts and Analysis - By Applications
9.2.5 Europe Pyrimethamine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pyrimethamine Market
9.2.5.1.1 Germany Pyrimethamine Market by Type
9.2.5.1.2 Germany Pyrimethamine Market by Applications
9.2.5.2 France Pyrimethamine Market
9.2.5.2.1 France Pyrimethamine Market by Type
9.2.5.2.2 France Pyrimethamine Market by Applications
9.2.5.3 Italy Pyrimethamine Market
9.2.5.3.1 Italy Pyrimethamine Market by Type
9.2.5.3.2 Italy Pyrimethamine Market by Applications
9.2.5.4 Spain Pyrimethamine Market
9.2.5.4.1 Spain Pyrimethamine Market by Type
9.2.5.4.2 Spain Pyrimethamine Market by Applications
9.2.5.5 United Kingdom Pyrimethamine Market
9.2.5.5.1 United Kingdom Pyrimethamine Market by Type
9.2.5.5.2 United Kingdom Pyrimethamine Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pyrimethamine Market Overview
9.3.2 Asia-Pacific Pyrimethamine Market Forecasts and Analysis
9.3.3 Asia-Pacific Pyrimethamine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Pyrimethamine Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Pyrimethamine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pyrimethamine Market
9.3.5.1.1 Australia Pyrimethamine Market by Type
9.3.5.1.2 Australia Pyrimethamine Market by Applications
9.3.5.2 China Pyrimethamine Market
9.3.5.2.1 China Pyrimethamine Market by Type
9.3.5.2.2 China Pyrimethamine Market by Applications
9.3.5.3 India Pyrimethamine Market
9.3.5.3.1 India Pyrimethamine Market by Type
9.3.5.3.2 India Pyrimethamine Market by Applications
9.3.5.4 Japan Pyrimethamine Market
9.3.5.4.1 Japan Pyrimethamine Market by Type
9.3.5.4.2 Japan Pyrimethamine Market by Applications
9.3.5.5 South Korea Pyrimethamine Market
9.3.5.5.1 South Korea Pyrimethamine Market by Type
9.3.5.5.2 South Korea Pyrimethamine Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pyrimethamine Market Overview
9.4.2 Middle East and Africa Pyrimethamine Market Forecasts and Analysis
9.4.3 Middle East and Africa Pyrimethamine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Pyrimethamine Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Pyrimethamine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pyrimethamine Market
9.4.5.1.1 South Africa Pyrimethamine Market by Type
9.4.5.1.2 South Africa Pyrimethamine Market by Applications
9.4.5.2 Saudi Arabia Pyrimethamine Market
9.4.5.2.1 Saudi Arabia Pyrimethamine Market by Type
9.4.5.2.2 Saudi Arabia Pyrimethamine Market by Applications
9.4.5.3 U.A.E Pyrimethamine Market
9.4.5.3.1 U.A.E Pyrimethamine Market by Type
9.4.5.3.2 U.A.E Pyrimethamine Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pyrimethamine Market Overview
9.5.2 South and Central America Pyrimethamine Market Forecasts and Analysis
9.5.3 South and Central America Pyrimethamine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Pyrimethamine Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Pyrimethamine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pyrimethamine Market
9.5.5.1.1 Brazil Pyrimethamine Market by Type
9.5.5.1.2 Brazil Pyrimethamine Market by Applications
9.5.5.2 Argentina Pyrimethamine Market
9.5.5.2.1 Argentina Pyrimethamine Market by Type
9.5.5.2.2 Argentina Pyrimethamine Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PYRIMETHAMINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PYRIMETHAMINE MARKET, KEY COMPANY PROFILES
12.1. EVALUATE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. IMPAX LABORATORIES, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NCBO BIOPORTAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PRN PHARMACAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SUDA PHARMACEUTICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TAJ ACCURA PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TARGETMOL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TURING PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Evaluate
2. GlaxoSmithKline plc
3. Impax Laboratories, Inc.
4. NCBO BioPortal
5. Pfizer, Inc.
6. PRN Pharmacal
7. SUDA Pharmaceuticals
8. Taj Accura Pharmaceuticals
9. TargetMol
10. Turing Pharmaceuticals
TIPRE00011117
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking